HOMEODEL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HOMEODEL Trademark

Serial Number: 79286977 • Registration: 6504468

HOMEODEL is a trademark filed by Laboratoire homéopathique D. Schmidt-Nagel SA on April 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Laboratoire homéopathique D. Schmidt-Nagel SA (2 trademarks)

Rue de Pré-Bouvier 27
Meyrin CH-1217 , CH

Entity Type: 33

Trademark Details

Filing Date

April 23, 2020

Registration Date

October 5, 2021

Published for Opposition

July 20, 2021

Goods & Services

Homeopathic supplements; homeopathic medicines; homeopathic anti-inflammatory ointments; homeopathic pharmaceuticals for use in the treatment of allergies, asthma, insomnia, sinus congestion, indigestion, hay fever and motion sickness; homeopathic pharmaceuticals for use in the treatment of dermatitis, dry skin, irritated skin, acne, sunburn, cracked skin, insect bites, minor skin wounds, rashes, warts, blisters, boils, canker sores, cradle cap and scars; homeopathic pharmaceuticals for use in the treatment of gynecological disorders, hot flashes, functional problems associated with menopause, disorders of the digestive system, intestinal diseases, gastroenterological diseases, nausea and urinary functional disorders; homeopathic pharmaceuticals for use in the treatment of anxiety, sleep disorders, nervousness, irritability, nerve pain, apprehensiveness, emotional palpitations and mental fatigue; homeopathic pharmaceuticals for use in the treatment of eye diseases, nose and throat diseases, rhinitis, colds, coughs, gum pain for children, restlessness and irritability; pharmaceutical products for the treatment of allergies, asthma, insomnia, sinus congestion, indigestion, hay fever, motion sickness, dermatitis, dry skin, irritated skin, acne, sunburn, cracked skin, insect bites, minor skin wounds, rashes, warts, blisters, boils, canker sores, cradle cap and scars; pharmaceutical products for the treatment of gynecological disorders, hot flashes, functional problems associated with menopause, disorders of the digestive system, intestinal diseases, gastroenterological diseases, nausea and urinary functional disorders; pharmaceutical products for the treatment of anxiety, sleep disorders, nervousness, irritability, nerve pain, apprehensiveness, emotional palpitations and mental fatigue; pharmaceutical products for the treatment of eye diseases, nose and throat diseases, rhinitis, colds, coughs, gum pain for children, restlessness, and irritability

Retail drug store services and wholesale store services all featuring homeopathic supplements, homeopathic medicines, homeopathic anti-inflammatory ointments, homeopathic pharmaceuticals, pharmaceuticals, balms for pharmaceutical use, decoctions for pharmaceutical use, lotions for pharmaceutical use, pills for pharmaceutical use, therapeutic agents and medicines; online retail store services featuring homeopathic supplements, homeopathic medicines, homeopathic anti-inflammatory ointments, homeopathic pharmaceuticals, pharmaceuticals, balms for pharmaceutical use, decoctions for pharmaceutical use, lotions for pharmaceutical use, pills for pharmaceutical use, therapeutic agents, and medicines

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jul 18, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 25, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 23, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 22, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 12, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 4, 2020 REPR